Positrigo ads

Final day at SNMMI in Los Angeles, Booth #1161. When we built NeuroLF, physicians asked for one thing above all: it has to match the image quality they are used to. No compromises. For amyloid imaging, you could argue you don't need state-of-the-art quality, that you can trade it for a more affordable system. After talking to the physicians, we moved away from that path quickly. That is exactly what we built. A dedicated brain PET with zero compromise on image quality, in a device that fits a standard office. If you're around, come see it for yourself at Booth #1161.

When we walk neurology practices through the pro forma P&L, it typically takes a few minutes for them to see it: the economics are straightforward. One of our first customers adopting brain PET imaging started with a projection of 20-30 patients per month. A few months later, they were close to 100, and have already signed for a second and third NeuroLF for their other locations. However, what kept many practices from getting started was the operational side. The Brain PET Accelerator Program was built with that in mind. It’s a comprehensive program that handles the full operational model so practices can focus on patient care. – Fully managed program. – No capital outlay. – $1M-2.5M contribution margin over 5 years. We handle the complexity, while you see the patients. Request your personalized Pro Forma here.

We handle the complexity, while you see the patients. The BrainPET Accelerator Program brings molecular neuroimaging directly to neurology practices. Fully managed program. No capital outlay. $1M-2.5M contribution margin over 5 years.

"It helped us get every other patient scanned weeks sooner." Dr. Michael Shriver, Director of Nuclear Medicine at ProScan–NCH, moved the amyloid backlog off his PET/CT and onto NeuroLF. Same diagnostic quality, qualitatively and quantitatively, while cutting weeks off the wait for oncology or cardiac patients. If you're attending the SNMMI Annual Meeting, come see yourself at Booth #1161.

The path from scheduling an amyloid PET to getting the read back runs anywhere from one to two months to six months. In Alzheimer's care, time to treatment is key. We built the Brain PET Accelerator Program so neurology practices can offer same-day confirmation without taking on the operational side themselves. – Fully managed program. – No capital outlay. – $1M-2.5M contribution margin over 5 years. We handle the complexity, while you see the patients. Request your personalized Pro Forma here.

We handle the complexity, while you see the patients. The BrainPET Accelerator Program brings molecular neuroimaging directly to neurology practices. Fully managed program. No capital outlay. $1M-2.5M contribution margin over 5 years. Request your proforma here.